Atara Biotherapeutics Inc
NASDAQ:ATRA
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
ROE Comparison
Atara Biotherapeutics Inc Competitors
| Country | US |
| Market Cap | 72.1m USD |
| ROE |
-2 018%
|
| Country | US |
| Market Cap | 293.6B USD |
| ROE |
35%
|
| Country | US |
| Market Cap | 142.7B USD |
| ROE |
136%
|
| Country | US |
| Market Cap | 101.6B USD |
| ROE |
23%
|
| Country | US |
| Market Cap | 97.8B USD |
| ROE |
16%
|
| Country | AU |
| Market Cap | 130.2B AUD |
| ROE |
15%
|
| Country | US |
| Market Cap | 82.6B USD |
| ROE |
26%
|
| Country | US |
| Market Cap | 43.1B USD |
| ROE |
-28%
|
| Country | US |
| Market Cap | 38.8B USD |
| ROE |
-29%
|
| Country | US |
| Market Cap | 27.7B USD |
| ROE |
8%
|
| Country | IE |
| Market Cap | 26.6B USD |
| ROE |
9%
|
Profitability Report
View the profitability report to see the full profitability analysis for Atara Biotherapeutics Inc.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on Atara Biotherapeutics Inc's most recent financial statements, the company has ROE of -2 017.8%.
You don't have any saved screeners yet
